» Articles » PMID: 24241912

Thrombin Generation and Atherosclerosis

Overview
Date 2013 Nov 19
PMID 24241912
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Atherosclerosis is a major cause of mortality worldwide. The important role inflammation plays in atherosclerosis is evident through the participation of inflammatory cells in the development and progression of the disease. Thrombin is the central protease of the coagulation cascade, involved in the formation of a hemostatic plug to avoid severe bleeding. In addition, thrombin is a key factor in regulating inflammatory processes, signaling through protease activated receptors. We propose that thrombin may be a relevant factor in the atherosclerosis coagulation-inflammation axis. Human histological data show abundant coagulation activity within atherosclerotic lesions with thrombin activity being related to atherosclerotic plaque development and (in)stability. Animal studies establish that the generated thrombin level relates to progression of atherosclerosis, with hypercoagulability producing advanced atherosclerosis in mice with an Apolipoprotein E-deficient (ApoE(-/-)) background. Several studies show that administration of direct oral anticoagulants, like dabigatran and rivaroxaban, attenuate atherosclerosis development in ApoE(-/-) mice. In this review we explore several mechanisms by which thrombin may operate in modifying the chronic process of atherosclerosis. One of the key elements may be the conversion of thrombin, from a physiological regulator of hemostasis towards an inflammation-mediator under pathophysiological conditions, contributing to a switch in the thrombin-activated protein C (APC) regulation. The ongoing inflammatory activity, indicated by the activation of pro-inflammatory cytokines, neutrophils and neutrophil extracellular traps, drive thrombin generation, while diminishing APC formation. The net result is accelerated pro-inflammatory and pro-thrombotic changes in blood and in the vessel wall. We conclude that these atherogenic influences of thrombin may be clinically relevant in the long-term. Further the treatment with long-term anticoagulant therapy deserves further attention as to its potential, vascular side effects.

Citing Articles

One immune cell to bind them all: platelet contribution to neurodegenerative disease.

Rodriguez Moore G, Melo-Escobar I, Stegner D, Bracko O Mol Neurodegener. 2024; 19(1):65.

PMID: 39334369 PMC: 11438031. DOI: 10.1186/s13024-024-00754-4.


PGC1-Alpha/Sirt3 Signaling Pathway Mediates the Anti-Pulmonary Fibrosis Effect of Hirudin by Inhibiting Fibroblast Senescence.

He B, Zeng Q, Tian Y, Luo Y, Liao M, Huang W Biomedicines. 2024; 12(7).

PMID: 39062010 PMC: 11274105. DOI: 10.3390/biomedicines12071436.


The Etiology of the Thrombotic Phenomena Involved in the Process of Coronary Artery Disease-What Is the Role of Thrombophilic Genes in the Development of This Pathology?.

Bararu Bojan I, Dobreanu S, Vladeanu M, Ciocoiu M, Badescu C, Plesoianu C Int J Mol Sci. 2024; 25(10).

PMID: 38791267 PMC: 11120830. DOI: 10.3390/ijms25105228.


The Complementary Effects of Dabigatran Etexilate and Exercise Training on the Development and Stability of the Atherosclerotic Lesions in Diabetic ApoE Knockout Mice.

Kadoglou N, Stasinopoulou M, Gkougkoudi E, Christodoulou E, Kostomitsopoulos N, Valsami G Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895867 PMC: 10609840. DOI: 10.3390/ph16101396.


Vitamin D Deficiency is Associated With Increased Plasminogen Activator Inhibitor 1/Plasminogen Activator Inhibitor 2 Ratio in Pregnancy.

Andersen M, Rudiger I, Vestergaard A, Palarasah Y, Bor P, Larsen A Clin Appl Thromb Hemost. 2023; 29:10760296231201855.

PMID: 37722759 PMC: 10510367. DOI: 10.1177/10760296231201855.


References
1.
de Jonge E, Dekkers P, Creasey A, Hack C, Paulson S, Karim A . Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia. Blood. 2000; 95(4):1124-9. View

2.
de Kruif M, van Gorp E, Keller T, Ossewaarde J, Ten Cate H . Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research. Cardiovasc Res. 2005; 65(2):317-27. DOI: 10.1016/j.cardiores.2004.09.031. View

3.
Engelmann B, Massberg S . Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2012; 13(1):34-45. DOI: 10.1038/nri3345. View

4.
Naldini A, Carney D, Pucci A, Pasquali A, Carraro F . Thrombin regulates the expression of proangiogenic cytokines via proteolytic activation of protease-activated receptor-1. Gen Pharmacol. 2002; 35(5):255-9. DOI: 10.1016/s0306-3623(01)00113-6. View

5.
Bajaj M, Ghosh M, Bajaj S . Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: physiologic and pathologic implications. J Thromb Haemost. 2007; 5(7):1493-9. DOI: 10.1111/j.1538-7836.2007.02604.x. View